Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
957 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04421820 | BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours | recruiting | Phase 1 / Phase 2 | 220 | Bold Therapeutics, Inc.INDUSTRY | 7 | May 18, 2026 | clinicaltrials |
| NCT05853965 | Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma(BELI(E)VE) | recruiting | Phase 1 / Phase 2 | 45 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | May 18, 2026 |
| clinicaltrials |
| NCT06757634 | Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) | recruiting | Phase 3 | 1,180 | Celcuity IncINDUSTRY | 22 | May 18, 2026 | clinicaltrials |
| NCT04765020 | Cardiorespiratory Fitness in Children and Adolescents After Cancer Treatment.(POWER) | recruiting | Phase 2 / Phase 3 | 56 | Universität Duisburg-EssenOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT05413850 | Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection | recruiting | Phase 1 / Phase 2 | 82 | Blue Earth Therapeutics LtdINDUSTRY | 5 | May 14, 2026 | clinicaltrials |
| NCT06417814 | A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(TROPION-Lung15) | recruiting | Phase 3 | 744 | AstraZenecaINDUSTRY | 27 | May 14, 2026 | clinicaltrials |
| NCT07531693 | Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer(PROSPER) | recruiting | — | 200 | Institut fuer FrauengesundheitOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT03686124 | ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors(ACTengine) | recruiting | Phase 1 / Phase 2 | 375 | Immatics US, Inc.INDUSTRY | 2 | May 13, 2026 | clinicaltrials |
| NCT05492682 | START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer | recruiting | Phase 1 | 15 | Valo Therapeutics OyINDUSTRY | 2 | May 12, 2026 | clinicaltrials |
| NCT04996914 | Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma(ASTrH) | recruiting | N/A | 30 | RWTH Aachen UniversityOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT05903833 | Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy(PIERCE) | recruiting | Phase 2 | 42 | AGO Research GmbHINDUSTRY | 1 | May 11, 2026 | clinicaltrials |
| NCT06697301 | Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. | recruiting | Phase 2 / Phase 3 | 740 | Eikon TherapeuticsINDUSTRY | 24 | May 8, 2026 | clinicaltrials |
| NCT07311083 | Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy(BallastImmun) | recruiting | N/A | 60 | Kliniken Essen-MitteOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT00669266 | Adrenal Tumors - Pathogenesis and Therapy | recruiting | — | 500 | University of WuerzburgOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT04043494 | International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma(LBL 2018) | recruiting | Phase 3 | 683 | University Hospital MuensterOTHER | 21 | May 6, 2026 | clinicaltrials |
| NCT07015190 | Neoadjuvant Darovasertib in Primary Uveal Melanoma | recruiting | Phase 3 | 520 | IDEAYA BiosciencesINDUSTRY | 21 | May 6, 2026 | clinicaltrials |
| NCT05099471 | Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia(VIWA-1) | recruiting | Phase 2 | 80 | Christian BuskeOTHER | 2 | May 5, 2026 | clinicaltrials |
| NCT06508931 | Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms(DALY PED) | recruiting | Phase 2 | 31 | Miltenyi Biomedicine GmbHINDUSTRY | 4 | May 5, 2026 | clinicaltrials |
| NCT07197632 | ioMRI in the Surgery of Brain Metastases.(MET-MRI) | recruiting | N/A | 154 | Technical University of MunichOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT00662090 | Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood(EWOG MDS 2006) | recruiting | — | 260 | University Hospital FreiburgOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT04731857 | Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes(EXGEFATU) | recruiting | — | 12,000 | University Hospital TuebingenOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06094101 | Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)(PerVision) | recruiting | Phase 1 / Phase 2 | 30 | University Hospital TuebingenOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06111105 | GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer | recruiting | — | 590 | Claus Lindbjerg AndersenOTHER | 5 | May 4, 2026 | clinicaltrials |
| NCT07564219 | BEAM-MM - β-Hydroxybutyrate-Enhanced Adaptive Immunity in Multiple Myeloma(BEAM-MM) | recruiting | N/A | 45 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT07564570 | Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma(SPRINT) | recruiting | N/A | 40 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06807359 | Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System | recruiting | Phase 1 / Phase 2 | 43 | SpectraCure ABINDUSTRY | 2 | May 1, 2026 | clinicaltrials |
| NCT07410247 | MPN Childhood Registry | recruiting | — | 500 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT04256317 | A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) | recruiting | Phase 2 / Phase 3 | 316 | Taiho Oncology, Inc.INDUSTRY | 10 | Apr 30, 2026 | clinicaltrials |
| NCT06792994 | A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic Lymphocytic Leukaemia (CLL) Treated Within First-line Studies of the GCLLSG(CLL2000) | recruiting | — | 2,000 | German CLL Study GroupOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT04613388 | Registry Study of Proton Radiotherapy in Lymphoma | recruiting | — | 200 | University Hospital HeidelbergOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT06416293 | Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and Physicians(WAVES) | recruiting | — | 2,000 | University Hospital AugsburgOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT06914544 | Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)(HYPOSTAT-III) | recruiting | N/A | 175 | University Hospital Schleswig-HolsteinOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT04916613 | ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)(GETUG-AFU 40) | recruiting | Phase 3 | 300 | UNICANCEROTHER | 12 | Apr 28, 2026 | clinicaltrials |
| NCT05045664 | Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody(FORTplus) | recruiting | Phase 3 | 100 | Heidelberg UniversityOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT06806059 | Preoperative Physical Activity Before Radical Cystectomy and the Impact on Morbidity(PRACTICE) | recruiting | N/A | 146 | Ludwig-Maximilians - University of MunichOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT05732623 | Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer(DEMETRA) | recruiting | — | 2,300 | San Raffaele UniversityOTHER | 6 | Apr 24, 2026 | clinicaltrials |
| NCT03383978 | Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma(CAR2BRAIN) | recruiting | Phase 1 | 42 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT03188874 | Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | recruiting | — | 15,000 | Technische Universität DresdenOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT03761108 | Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma(LINKER-MM1) | recruiting | Phase 1 / Phase 2 | 387 | Regeneron PharmaceuticalsINDUSTRY | 7 | Apr 20, 2026 | clinicaltrials |
| NCT07255638 | A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany | recruiting | — | 80 | Blueprint Medicines CorporationINDUSTRY | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07537491 | KIA-Korekt: Staged Unimodal-to-Multimodal AI Evaluation for Perioperative Risk Prediction in Colorectal Cancer(KIA-Korekt) | recruiting | — | 910 | Rene MantkeOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT05580562 | ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)(ACTION) | recruiting | Phase 3 | 510 | Jazz PharmaceuticalsINDUSTRY | 18 | Apr 16, 2026 | clinicaltrials |
| NCT06205953 | A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)(EUREKA) | recruiting | — | 400 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 6 | Apr 16, 2026 | clinicaltrials |
| NCT06312644 | Study of Ultomiris® (Ravulizumab) Safety in Pregnancy | recruiting | — | 75 | Alexion Pharmaceuticals, Inc.INDUSTRY | 7 | Apr 16, 2026 | clinicaltrials |
| NCT07519811 | LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL)(oncOPAL) | recruiting | N/A | 150 | Technical University of MunichOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT03735992 | Mind-body Medicine for Patients With Malignant Hematological Diseases | recruiting | N/A | 94 | Universität Duisburg-EssenOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT02304913 | Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy(OralAcu) | recruiting | N/A | 75 | Universität Duisburg-EssenOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT06122584 | Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer | recruiting | Phase 3 | 380 | ABX advanced biochemical compounds GmbHINDUSTRY | 6 | Apr 14, 2026 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials